MedPath

Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)

Phase 4
Terminated
Conditions
Meniere Disease
Interventions
Registration Number
NCT02529475
Lead Sponsor
University Hospital, Grenoble
Brief Summary

* This prospective study aims to better characterize inner ear's perilymphatic structures with Magnetic Resonance Imaging using contrast media and delayed injection in healthy subjects

* MR Perfusion Imaging will be assess in both cochlea as well

* Primary auditory brain pathways will be evaluated through MR diffusion imaging

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Major subjects of over 40 years (mean age of Meniere's disease 40 to 50 years)
  • Informed consent signed
  • Medical examination performed prior to participation in research
  • Patients without history of inner ear disease
  • Recipient of a French social security scheme
Exclusion Criteria
  • Patients minors
  • Patients on a legal protection regime type guardianship
  • Respiratory pathologies, cardiovascular, renal, diabetes
  • Claustrophobia
  • Contraindications to exposure to a magnetic field
  • Contraindications to injecting Dotarem ®

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Gadoteric acidGadoteric acidGadoteric acid 0.2 mmol/kg
Primary Outcome Measures
NameTimeMethod
Gadolinium enhancement in inner ear structures as measured by MR T1 Weighted ImagingOne MR scan (4 hours)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

GrenobleUniversityHospital

🇫🇷

Grenoble, France

Hôpital Charles Nicolle

🇫🇷

Rouen, France

Hôpital Lariboisière

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath